SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-028086
Filing Date
2021-12-08
Accepted
2021-12-08 16:26:02
Documents
17
Period of Report
2021-12-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cenb20211208_8k.htm   iXBRL 8-K 40964
2 EXHIBIT 10.1 ex_314624.htm EX-10.1 68282
3 EXHIBIT 10.2 ex_314625.htm EX-10.2 35182
4 EXHIBIT 17.1 ex_314626.htm EX-17.1 873
9 ex01.jpg GRAPHIC 58031
  Complete submission text file 0001437749-21-028086.txt   380671

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA noticker-20211206.xsd EX-101.SCH 3625
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE noticker-20211206_def.xml EX-101.DEF 10718
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE noticker-20211206_lab.xml EX-101.LAB 14320
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE noticker-20211206_pre.xml EX-101.PRE 10768
10 EXTRACTED XBRL INSTANCE DOCUMENT cenb20211208_8k_htm.xml XML 2378
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55557 | Film No.: 211478979
SIC: 2834 Pharmaceutical Preparations